PMV PHARMACEUTICALS, INC. Gain (Loss) on Termination of Lease
PMV PHARMACEUTICALS, INC. (PMVP) reported Gain (Loss) on Termination of Lease of $24.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnTerminationOfLease · last filed 2026-08-14
- PMV PHARMACEUTICALS, INC. gain (loss) on termination of lease for the quarter ending 2026-03-31 was $24.00K.
- PMV PHARMACEUTICALS, INC. gain (loss) on termination of lease for fiscal 2024 was -$4.60M.
| Period end | Gain (Loss) on Termination of Lease 3 month | Gain (Loss) on Termination of Lease 6 month | Gain (Loss) on Termination of Lease 12 month |
|---|---|---|---|
| 2026-06-30 | $24.00K 10-Q · filed 2026-08-14 | ||
| 2026-03-31 | $24.00K 10-Q · filed 2026-05-12 | ||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-14 | ||
| 2024-12-31 | -$4.60M 10-K · filed 2026-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |